The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
27750148 |
7 |
Fragment-based discovery of novel pentacyclic triterpenoid derivatives as cholesteryl ester transfer protein inhibitors. |
China Pharmaceutical University |
27490022 |
29 |
Design, synthesis and biological evaluation of novel cholesteryl ester transfer protein inhibitors bearing a cycloalkene scaffold. |
Shenyang Pharmaceutical University |
27256912 |
36 |
Discovery of hydroxyl 1,2-diphenylethanamine analogs as potent cholesterol ester transfer protein inhibitors. |
Bristol-Myers Squibb Pharmaceutical Research Institute |
26985312 |
36 |
Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided Approach. |
Merck Research Laboratories |
27010500 |
19 |
Design, synthesis and biological evaluation of N,N-3-phenyl-3-benzylaminopropanamide derivatives as novel cholesteryl ester transfer protein inhibitor. |
Shenyang Pharmaceutical University |
26993745 |
19 |
Discovery of novel N,N-3-phenyl-3-benzylaminopropionanilides as potent inhibitors of cholesteryl ester transfer protein in vivo. |
Shenyang Pharmaceutical University |
26200936 |
39 |
Applications of Fluorine in Medicinal Chemistry. |
Bristol-Myers Squibb Research and Development |
25127148 |
1 |
Some molecular targets for antihyperlipidemic drug research. |
Banasthali University |
25265559 |
19 |
Potent cholesteryl ester transfer protein inhibitors of reduced lipophilicity: 1,1'-spiro-substituted hexahydrofuroquinoline derivatives. |
Boehringer Ingelheim Pharma |
24424134 |
76 |
Diphenylpyridylethanamine (DPPE)-based aminoheterocycles as cholesteryl ester transfer protein inhibitors. |
Bristol-Myers Squibb |
22650305 |
64 |
Diphenylpyridylethanamine (DPPE) derivatives as cholesteryl ester transfer protein (CETP) inhibitors. |
Bristol-Myers Squibb |
22995620 |
60 |
Identification of a potent and metabolically stable series of fluorinated diphenylpyridylethanamine-based cholesteryl ester transfer protein inhibitors. |
Bristol-Myers Squibb |
22543028 |
39 |
Design and synthesis of new tetrahydroquinolines derivatives as CETP inhibitors. |
Eli Lilly |
22497761 |
59 |
Design, synthesis and structure-activity-relationship of 1,5-tetrahydronaphthyridines as CETP inhibitors. |
Eli Lilly |
18374566 |
129 |
2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: optimization via array synthesis. |
Bristol-Myers Squibb Pharmaceutical Research Institute |
17521912 |
15 |
The biology and chemistry of hyperlipidemia. |
Sinhgad College of Pharmacy |
11000011 |
28 |
bis(2-(Acylamino)phenyl) disulfides, 2-(acylamino)benzenethiols, and S-(2-(acylamino)phenyl) alkanethioates as novel inhibitors of cholesteryl ester transfer protein. |
Research Triangle Institute |
| 10 |
CETP inhibitory activity of ceramides, isolated from the gorgonian Acabaria Undulata |
TBA |
| 13 |
Wiedendiol-A and -B, cholesteryl ester transfer protein inhibitors from the marine sponge Xestospongia wiedenmayeri |
TBA |
24900324 |
8 |
Discovery of substituted biphenyl oxazolidinone inhibitors of cholesteryl ester transfer protein. |
TBA |
22142541 |
24 |
SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitors. |
Merck Sharp & Dohme |
21682257 |
11 |
Biphenyl-substituted oxazolidinones as cholesteryl ester transfer protein inhibitors: modifications of the oxazolidinone ring leading to the discovery of anacetrapib. |
Merck Research Laboratories |
21398121 |
51 |
2-(4-Carbonylphenyl)benzoxazole inhibitors of CETP: attenuation of hERG binding and improved HDLc-raising efficacy. |
Merck Research Laboratories |
21147531 |
44 |
2-(4-carbonylphenyl)benzoxazole inhibitors of CETP: scaffold design and advancement in HDLc-raising efficacy. |
Merck Research Laboratories |
21094047 |
69 |
2-Arylbenzoxazoles as CETP inhibitors: raising HDL-C in cynoCETP transgenic mice. |
Merck Research Laboratories |
21041082 |
18 |
Design of a novel class of biphenyl CETP inhibitors. |
Merck Sharp & Dohme |
20667734 |
18 |
Synthesis of a series of novel 2,4,5-trisubstituted selenazole compounds as potential PLTP inhibitors. |
Beijing Institute of Pharmacology and Toxicology |
20137927 |
43 |
Novel tetrahydrochinoline derived CETP inhibitors. |
Bayer Healthcare |
20036121 |
49 |
2-Arylbenzoxazoles as CETP inhibitors: substitution and modification of the alpha-alkoxyamide moiety. |
Merck Research Laboratories |
20089400 |
27 |
Synthesis and discovery of 2,3-dihydro-3,8-diphenylbenzo[1,4]oxazines as a novel class of potent cholesteryl ester transfer protein inhibitors. |
Johnson & Johnson Pharmaceutical Research and Development |
| 12 |
Substituted 1,3,5-triazines as cholesteryl ester transfer protein inhibitors |
TBA |
| 8 |
Phosphonate-containing analogs of cholesteryl ester as novel inhibitors of cholesteryl ester transfer protein |
TBA |
| 14 |
Novel inhibitors of cholesteryl ester transfer protein |
TBA |
19339179 |
24 |
Design and synthesis of potent inhibitors of cholesteryl ester transfer protein (CETP) exploiting a 1,2,3,4-tetrahydroquinoline platform. |
Johnson & Johnson Pharmaceutical Research & Development |
19236017 |
8 |
Design, synthesis, and biological evaluation of (2R,alphaS)-3,4-dihydro-2-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)-phenyl]-alpha-(trifluoromethyl)-1(2H)-quinolineethanol as potent and orally active cholesteryl ester transfer protein inhibitor. |
Johnson and Johnson Pharmaceutical Research and Development |
17604633 |
85 |
2D Quantitative structure-activity relationship studies on a series of cholesteryl ester transfer protein inhibitors. |
Universidade Federal Da Bahia |
17331716 |
40 |
Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors. |
Array Biopharma |
15975789 |
28 |
Dibenzodioxocinones--a new class of CETP inhibitors. |
Bayer Healthcare Pharma Research |
15109658 |
19 |
S-(2-(acylamino)phenyl) 2,2-dimethylpropanethioates as CETP inhibitors. |
Central Pharmaceutical Research Institute |
12747787 |
106 |
Discovery of a simple picomolar inhibitor of cholesteryl ester transfer protein. |
Pfizer |
12190312 |
67 |
Chiral N,N-disubstituted trifluoro-3-amino-2-propanols are potent inhibitors of cholesteryl ester transfer protein. |
Pharmacia |
11425523 |
20 |
Novel heteroaryl replacements of aromatic 3-tetrafluoroethoxy substituents in trifluoro-3-(tertiaryamino)-2-propanols as potent inhibitors of cholesteryl ester transfer protein. |
Pharmacia |
11101348 |
22 |
Discovery of chiral N,N-disubstituted trifluoro-3-amino-2-propanols as potent inhibitors of cholesteryl ester transfer protein. |
Pfizer |
31780304 |
7 |
Synthesis, biological evaluation and SAR studies of ursolic acid 3?-ester derivatives as novel CETP inhibitors. |
Nanjing Medical University |
31223447 |
44 |
Discovery of a Lead Triphenylethanamine Cholesterol Ester Transfer Protein (CETP) Inhibitor. |
Bristol-Myers Squibb |
9871749 |
3 |
A depsipeptide fungal metabolite inhibitor of cholesteryl ester transfer protein. |
Schering-Plough Research Institute |
11405654 |
1 |
Combinatorial synthesis of cholesterol ester transfer protein-mRNA ligands and screening by nondenaturating gel-electrophoresis. |
Johann Wolfgang Goethe-Universit£T Frankfurt/Main |
28802120 |
14 |
Discovery of pentacyclic triterpene 3?-ester derivatives as a new class of cholesterol ester transfer protein inhibitors. |
China Pharmaceutical University |
29035537 |
19 |
Discovery of a Novel Piperidine-Based Inhibitor of Cholesteryl Ester Transfer Protein (CETP) That Retains Activity in Hypertriglyceridemic Plasma. |
Novartis Institutes For Biomedical Research |
23327640 |
24 |
Phenolic compounds with pancreatic lipase inhibitory activity from Korean yam (Dioscorea opposita). |
Seoul National University |
15225695 |
64 |
4-Acylamino-6-arylfuro[2,3-d]pyrimidines: potent and selective glycogen synthase kinase-3 inhibitors. |
Tsukuba Research Laboratories |